News Quantified

FENC – fennec pharmaceuticals inc. (US:NASDAQ)

Adherex Technologies (NASDAQ:FENC) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $18.00 price target on the stock.

12/29

12:13 am

fenc

Medium

Southpoint sells $7.5M worth stock of Fennec Pharmaceuticals [Seeking Alpha]

Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) [Yahoo! Finance]

Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)

Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 [Seeking Alpha]

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}